FIGS

+ Watchlist + Portfolio

FIGS, Inc. Class A

Physical products Consumer brandTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $13.52
52-Week Range: $6.77 – $17.48
Market Cap: $2.26B
P/E (TTM): 41.29
EPS (TTM): 0.33
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 5.10
PEG Ratio: —
Return on Equity: 14.76%
Return on Assets: 7.75%
Gross Margin: 68.91%
Operating Margin: 17.93%
Profit Margin: 8.72%
Current Ratio: 4.96
Debt/Equity: 0.13
Total Debt: $57.67M
Free Cash Flow: $78.62M
Revenue Growth: 28.80%
Earnings Growth: 275.00%
Enterprise Value: $2.01B

FIGS Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$505.83M	$545.65M	$555.56M	$631.10M
Cost of Revenue	$151.38M	$168.68M	$179.94M	$211.26M
Gross Profit	$354.46M	$376.96M	$375.62M	$419.84M
Selling, General & Admin	$316.79M	$342.92M	$373.36M	$381.69M
Operating Expenses	$316.79M	$342.92M	$373.36M	$381.69M
Operating Income	$37.67M	$34.05M	$2.27M	$38.15M
EBITDA	$39.59M	$36.99M	$8.96M	$47.18M
Pretax Income	$38.73M	$40.81M	$14.34M	$47.21M
Income Tax	$17.54M	$18.17M	$11.62M	$12.96M
Net Income	$21.19M	$22.64M	$2.72M	$34.25M
Diluted EPS	0.11	0.12	0.02	0.19
Diluted Shares	187.55M	182.41M	180.10M	179.49M

FIGS Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$159.78M	$144.17M	$85.64M	$81.98M
Receivables	$6.87M	$7.47M	$8.63M	$6.27M
Inventory	$177.98M	$119.04M	$115.76M	$127.97M
Current Assets	$356.50M	$385.66M	$382.77M	$447.29M
Total Assets	$395.06M	$473.21M	$509.79M	$580.00M
Current Liabilities	$71.39M	$57.29M	$90.14M	$90.52M
Total Debt	$19.16M	$47.11M	$53.03M	$60.00M
Total Liabilities	$87.33M	$96.36M	$132.66M	$142.53M
Retained Earnings	$39.12M	$61.75M	$64.47M	$98.72M
Shareholders' Equity	$307.74M	$376.85M	$377.13M	$437.46M
Working Capital	$285.11M	$328.37M	$292.62M	$356.76M

FIGS Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$35.33M	$100.92M	$81.16M	$61.17M
Capital Expenditure	-$5.35M	-$16.35M	-$17.02M	-$8.17M
Free Cash Flow	-$40.68M	$84.57M	$64.14M	$53.00M
Depreciation & Amortisation	$1.92M	$2.94M	$6.69M	$9.04M
Stock-Based Compensation	$37.46M	$45.80M	$42.67M	$26.87M
Investing Cash Flow	-$5.85M	-$117.19M	-$94.92M	-$63.96M
Financing Cash Flow	$3.52M	$670.00K	-$44.77M	-$969.00K
Share Repurchases	$0.00	$0.00	-$45.45M	-$2.69M
Net Change in Cash	-$37.66M	-$15.60M	-$58.53M	-$3.76M

FIGS Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$124.90M	$152.64M	$151.66M	$201.90M	$159.90M	$196.62M
Cost of Revenue	$40.44M	$50.39M	$45.59M	$74.83M	$51.60M	$48.76M
Gross Profit	$84.46M	$102.25M	$106.07M	$127.07M	$108.30M	$147.85M
Selling, General & Admin	$84.67M	$92.33M	$96.43M	$108.26M	$103.81M	$112.59M
Operating Expenses	$84.67M	$92.33M	$96.43M	$108.26M	$103.81M	$112.59M
Operating Income	-$211.00K	$9.91M	$9.63M	$18.81M	$4.48M	$35.26M
EBITDA	$1.79M	$12.07M	$11.96M	$21.36M	$7.89M	$37.63M
Pretax Income	$1.86M	$12.03M	$11.96M	$21.35M	$6.45M	$36.88M
Income Tax	$1.97M	$4.93M	$3.21M	$2.85M	$157.00K	$8.50M
Net Income	-$102.00K	$7.10M	$8.75M	$18.51M	$6.29M	$28.38M
Diluted EPS	0.00	0.04	0.05	0.10	0.03	0.15
Diluted Shares	162.47M	172.93M	180.88M	190.01M	196.09M	195.14M

FIGS Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$90.01M	$50.85M	$46.45M	$81.98M	$74.30M	$108.54M
Receivables	$6.55M	$9.13M	$12.22M	$6.27M	$5.24M	$23.29M
Inventory	$131.58M	$135.53M	$151.23M	$127.97M	$139.38M	$119.56M
Current Assets	$399.71M	$393.61M	$418.02M	$447.29M	$432.19M	$452.93M
Total Assets	$522.31M	$517.12M	$544.74M	$580.00M	$563.44M	$582.68M
Current Liabilities	$100.97M	$78.36M	$86.66M	$90.52M	$80.20M	$91.38M
Total Debt	$51.33M	$51.70M	$54.12M	$60.00M	$60.60M	$57.67M
Total Liabilities	$140.78M	$120.59M	$131.41M	$142.53M	$132.80M	$140.31M
Retained Earnings	$64.37M	$71.47M	$80.22M	$98.72M	$105.01M	$133.39M
Shareholders' Equity	$381.54M	$396.53M	$413.33M	$437.46M	$430.64M	$442.37M
Working Capital	$298.74M	$315.25M	$331.36M	$356.76M	$351.99M	$361.54M

FIGS Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$9.23M	-$12.43M	$3.44M	$60.93M	-$3.20M	$46.86M
Capital Expenditure	-$1.31M	-$1.09M	-$2.91M	-$2.86M	-$2.42M	-$2.60M
Free Cash Flow	$7.92M	-$13.52M	$531.00K	$58.06M	-$5.63M	$44.26M
Depreciation & Amortisation	$2.00M	$2.15M	$2.33M	$2.56M	$3.41M	$2.37M
Stock-Based Compensation	$7.24M	$7.62M	$6.83M	$5.19M	$5.45M	$6.73M
Investing Cash Flow	-$2.18M	-$26.91M	-$8.96M	-$25.90M	$13.80M	$10.92M
Financing Cash Flow	-$2.69M	$185.00K	$1.13M	$401.00K	-$18.26M	-$23.48M
Share Repurchases	-$2.69M	$0.00	$0.00	$0.00	-$8.80M	-$24.02M
Net Change in Cash	$4.36M	-$39.16M	-$4.39M	$35.43M	-$7.67M	$34.30M

Market Snapshot

About

FIGS, Inc. is a direct-to-consumer healthcare apparel and lifestyle brand specializing in premium medical scrubs and related products. The company designs, manufactures, and sells antimicrobial, moisture-wicking scrubs and other medical apparel primarily targeting healthcare professionals. FIGS operates through an e-commerce platform and has built a strong brand presence among nurses, doctors, and other medical workers through social media and community engagement. The company has expanded beyond basic scrubs to include underscrubs, outerwear, compression socks, and lifestyle items. FIGS went public in 2021 and continues to grow its market share in the healthcare apparel industry through product innovation and direct relationships with healthcare workers.